Robert Weinstein

Insider Reports History

Entity
Individual
Location
3960 Howard Hughes Parkway, Suite 500, Las Vegas, NV
Signature
/s/ Abbey MacDonald, Power of Attorney for: Robert Weinstein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Weinstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
XWELL, Inc. Director Common Stock 156K $269K $1.72 May 30, 2023 Direct
Synaptogenix, Inc. Chief Financial Officer Common Stock, par value $0.0001 per share 33.2K $38.9K $1.17 Dec 16, 2022 Direct
Synaptogenix, Inc. Chief Financial Officer Stock Option (Right to Buy) 75K Nov 15, 2022 Direct
PharmaCyte Biotech, Inc. Director Stock Option (Right to Buy) 38K Apr 30, 2024 Direct

Insider Reports Filed by Robert Weinstein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PMCB PharmaCyte Biotech, Inc. Apr 30, 2024 1 $0 4 Jul 17, 2024 Director
PMCB PharmaCyte Biotech, Inc. Nov 20, 2023 1 $0 4 Nov 22, 2023 Director
XWEL XWELL, Inc. May 30, 2023 1 $6.18K 4 May 31, 2023 Director
OBLG Oblong, Inc. May 29, 2023 0 $0 3 Jun 1, 2023 Director
XWEL XWELL, Inc. May 26, 2023 1 $6.25K 4 May 30, 2023 Director
XWEL XWELL, Inc. Jan 5, 2023 1 $0 4/A Jan 9, 2023 Director
SNPX Synaptogenix, Inc. Dec 16, 2022 1 -$31.6K 4 Dec 20, 2022 Chief Financial Officer
SNPX Synaptogenix, Inc. Nov 15, 2022 1 $0 4/A Dec 1, 2022 Chief Financial Officer
PMCB PharmaCyte Biotech, Inc. Nov 14, 2022 0 $0 3 Nov 16, 2022 Director
XWEL XpresSpa Group, Inc. Apr 20, 2022 1 -$47.7K 4 Apr 22, 2022 Director
XWEL XpresSpa Group, Inc. Jan 26, 2022 2 $0 4 Jan 31, 2022 Director
XWEL XpresSpa Group, Inc. Jan 19, 2022 1 -$70.2K 4 Jan 21, 2022 Director
XWEL XpresSpa Group, Inc. Oct 20, 2021 1 -$90.2K 4 Oct 22, 2021 Director
XWEL XpresSpa Group, Inc. Jul 29, 2021 1 $0 4 Jul 30, 2021 Director
SNPX Synaptogenix, Inc. Jul 13, 2021 1 $0 4 Jul 15, 2021 Chief Financial Officer
SNPX Synaptogenix, Inc. Jun 4, 2021 0 $0 3 Jun 14, 2021 Chief Financial Officer